Search

Search Constraints

You searched for: Author/Creator Stentoft, Jesper

Search Results

3. Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study. (26th August 2022)

5. Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. (2nd September 2019)

8. Long‐term tolerability and efficacy after initial PegIFN‐α addition to dasatinib in CML‐CP: Five‐year follow‐up of the NordCML007 study. (31st August 2021)

9. Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study. Issue 7 (July 2015)